CS logo
small CS logo
Center for Vaccine Development, Mali

Bamako, Mali

About Center for Vaccine Development, Mali


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Maryland, Baltimore
5
London School of Hygiene and Tropical Medicine
2
National Institute of Allergy and Infectious Diseases (NIAID)
2
ANRS, Emerging Infectious Diseases
1
Center for Vaccine Development - Mali
1
Emory University
1
PATH
1
Serum Institute of India Pvt. Ltd.
1
Shanghai Zerun Biotechnology Co.,Ltd
1
Walvax Biotechnology Co., Ltd.
1
Total Rows: 10

Clinical Trials at Center for Vaccine Development, Mali


During the past decade, Center for Vaccine Development, Mali conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000000222211440000001100000000Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali
2006-04-01
2009-09-01
Completed
1,757
Study on the Impact of Vaccination With a Conjugate Vaccine on Meningococcal Carriage
2010-05-01
2012-06-01
Completed
33,000
A Case-control Study of the Efficacy of a New Serogroup A Meningococcal Conjugate Vaccine (MenAfriVac) in Mali and Niger
2012-02-01
2013-11-01
Withdrawn
0
Maternal Flu Vaccine Trial in Bamako, Mali
2011-09-12
2014-01-01
Completed
4,193
Phase 1 Trial of Ebola Vaccine in Mali
2014-10-01
2016-04-20
Completed
91
Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali
2014-10-01
2015-03-01
Completed
600
Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)
2015-03-01
2016-09-27
Completed
60
Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants
2019-01-24
2020-07-01
Completed
399

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Center for Vaccine Development, Mali" #1 sponsor was "University of Maryland, Baltimore" with 5 trials, followed by "London School of Hygiene and Tropical Medicine" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "ANRS, Emerging Infectious Diseases" with 1 trials sponsored and "Center for Vaccine Development - Mali" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Vaccine Development, Mali" #1 collaborator was "Bill and Melinda Gates Foundation" with 4 trials as a collaborator, "Center for Vaccine Development - Mali" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Wellcome Trust" with 2 trials as a collaborator and "APHP" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Maryland,Baltimore: 5University of Maryland,Baltimore: 5London School ofHygiene and TropicalMedicine: 2London School ofHygiene and TropicalMedicine: 2National Institute ofAllergy and InfectiousDiseases (NIAID): 2National Institute ofAllergy and InfectiousDiseases (NIAID): 2ANRS, EmergingInfectious Diseases: 1ANRS, EmergingInfectious Diseases: 1Center for VaccineDevelopment - Mali: 1Center for VaccineDevelopment - Mali: 1Emory University: 1Emory University: 1PATH: 1PATH: 1Serum Institute of IndiaPvt. Ltd.: 1Serum Institute of IndiaPvt. Ltd.: 1Shanghai ZerunBiotechnology Co.,Ltd:1Shanghai ZerunBiotechnology Co.,Ltd:1Walvax BiotechnologyCo., Ltd.: 1Walvax BiotechnologyCo., Ltd.: 1

Created with Highcharts 11.1.0Top CollaboratorsBill and Melinda GatesFoundation: 4Bill and Melinda GatesFoundation: 4Center for VaccineDevelopment - Mali: 3Center for VaccineDevelopment - Mali: 3National Institute ofAllergy and InfectiousDiseases (NIAID): 3National Institute ofAllergy and InfectiousDiseases (NIAID): 3Wellcome Trust: 2Wellcome Trust: 2APHP: 1APHP: 1CEPI: 1CEPI: 1Innovative clinicalresearch network invaccinology (IREIVAC):1Innovative clinicalresearch network invaccinology (IREIVAC):1Institut National de laSanté Et de laRecherche Médicale,France: 1Institut National de laSanté Et de laRecherche Médicale,France: 1Leidos BiomedicalResearch, Inc.: 1Leidos BiomedicalResearch, Inc.: 1Public Health England: 1Public Health England: 1

Clinical Trials Conditions at Center for Vaccine Development, Mali


According to Clinical.Site data, the most researched conditions in "Center for Vaccine Development, Mali" are "COVID-19" (2 trials), "Ebola Virus Disease" (2 trials), "Hemorrhagic Fever" (2 trials), "Meningitis" (2 trials) and "Clostridium Difficile Immunisation" (1 trials). Many other conditions were trialed in "Center for Vaccine Development, Mali" in a lesser frequency.

Clinical Trials Intervention Types at Center for Vaccine Development, Mali


Most popular intervention types in "Center for Vaccine Development, Mali" are "Biological" (12 trials), "Other" (3 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ad26.COV2.S" (1 trials), "Azithromycin to infants" (1 trials), "Azithromycin to pregnant women" (1 trials), "Booster-MVA-BN® Filo or saline placebo" (1 trials) and "Bubble CPAP" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Center for Vaccine Development, Mali


The vast majority of trials in "Center for Vaccine Development, Mali" are 14 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Center for Vaccine Development, Mali


Currently, there are NaN active trials in "Center for Vaccine Development, Mali". 2 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Center for Vaccine Development, Mali, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Center for Vaccine Development, Mali, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 4: 5Phase 4: 5Phase 1: 3Phase 1: 3Phase 2: 3Phase 2: 3Not Applicable: 2Not Applicable: 2Phase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Active, not recruiting: 2Active, not recruiting: 2Not yet recruiting: 2Not yet recruiting: 2Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1Unknown status: 1Unknown status: 1Withdrawn: 1Withdrawn: 1